Szarek, M., Amarenco, P., Callahan, A., Goldstein, L. B., Sillesen, H., Welch, K. M., & SPARCL Committees and Investigators. (2020). Reply: Hemorrhagic Stroke, All-Cause Death, and Intensive LDL-C Lowering: Evidence From SPARCL and Beyond. J Am Coll Cardiol, 76(7), 886–888. https://doi.org/10.1016/j.jacc.2020.06.042

Szarek, Michael, Pierre Amarenco, Alfred Callahan, Larry B. Goldstein, Henrik Sillesen, K Michael Welch, and SPARCL Committees and Investigators. “Reply: Hemorrhagic Stroke, All-Cause Death, and Intensive LDL-C Lowering: Evidence From SPARCL and Beyond.” J Am Coll Cardiol 76, no. 7 (August 18, 2020): 886–88. https://doi.org/10.1016/j.jacc.2020.06.042.

Szarek M, Amarenco P, Callahan A, Goldstein LB, Sillesen H, Welch KM, et al. Reply: Hemorrhagic Stroke, All-Cause Death, and Intensive LDL-C Lowering: Evidence From SPARCL and Beyond. J Am Coll Cardiol. 2020 Aug 18;76(7):886–8.

Szarek, Michael, et al. “Reply: Hemorrhagic Stroke, All-Cause Death, and Intensive LDL-C Lowering: Evidence From SPARCL and Beyond.” J Am Coll Cardiol, vol. 76, no. 7, Aug. 2020, pp. 886–88. Pubmed, doi:10.1016/j.jacc.2020.06.042.

Szarek M, Amarenco P, Callahan A, Goldstein LB, Sillesen H, Welch KM, SPARCL Committees and Investigators. Reply: Hemorrhagic Stroke, All-Cause Death, and Intensive LDL-C Lowering: Evidence From SPARCL and Beyond. J Am Coll Cardiol. 2020 Aug 18;76(7):886–888.